Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study.

Open Respir Arch

Sección de Alergología, Servicio de Neumología y Alergia, Hospital Clínic de Barcelona, Universitat Autònoma de Barcelona, IDIBAPS, CIBER de Enfermedades Respiratorias (CIBERES), 28029 Madrid, Spain.

Published: January 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369590PMC
http://dx.doi.org/10.1016/j.opresp.2023.100232DOI Listing

Publication Analysis

Top Keywords

clinical consequences
4
consequences overuse
4
overuse short-acting
4
short-acting β2-adrenergic
4
β2-adrenergic agonists
4
agonists saba
4
saba treatment
4
treatment asthma
4
asthma spain
4
spain sabina
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!